AbCellera Biologics Insider Trades

ABCL

Track insider trading activity from AbCellera Biologics executives and directors. See which insiders are buying and selling ABCL stock.

Trades Last 12 Months

ABCL Price

All Insider Trades for AbCellera Biologics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Seely Lynn Director
Holding Value $1.03M 152,207 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 152,207 shares
$7.85
$6.74
Sandor Victor Director
Holding Value $1.03M 152,207 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 152,207 shares
$7.85
$6.74
Quake Stephen Director
Holding Value $2.07M 306,633 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$589k 111,701 shares
$5.27
$6.74
Hayden Michael R Director
Holding Value $6.82M 1,011,544 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$589k 111,701 shares
$5.27
$6.74
Holding Value $7.69M 1,141,544 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$589k 111,701 shares
$5.27
$6.74
Holding Value $378M 56,134,097 shares
Last Trade
Feb 27, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$131k 38,000 shares
$3.44
$6.74
Booth Andrew Chief Financial Officer
Holding Value $1.32M 195,600 shares
Last Trade
Feb 27, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$146k 42,600 shares
$3.42
$6.74
Lecault Veronique Chief Technology Officer
Holding Value $35.1M 5,201,069 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.84M 539,265 shares
$3.42
$6.74
Stimart Tryn Chief Legal Officer
Holding Value $31.3M 4,646,012 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.84M 539,265 shares
$3.42
$6.74
Hansen Carl L. G. 10% owner, Chief Executive Officer
Holding Value $88.3M 13,096,837 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.2M 2,106,505 shares
$3.42
$6.74
Lo Andrew Director
Holding Value $3.65M 541,354 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$752k 238,864 shares
$3.15
$6.74
Hamer John Director
Holding Value $869k 128,862 shares
Last Trade
Sep 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.33M 137,351 shares
$16.93
$6.74
Falconer Ester Chief Technology Officer
Holding Value $5.9M 875,000 shares
Last Trade
Sep 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.8M 875,000 shares
$16.89
$6.74
Dcvc Bio, L.P. 10% owner
Holding Value $162M 24,105,761 shares
Last Trade
Jun 18, 2021 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$116M 5,000,000 shares
$23.19
$6.74
Thiel Peter Director
Holding Value $2.7M 401,050 shares
Last Trade
Dec 15, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$18.8M 401,050 shares
$46.99
$6.74

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up